COVID-19：中国シノファームのワクチン：ペルーで｢試験の中断｣（動画）：
COVID-19: China Sinopharm Vaccine: “Trial Discontinuation” in Peru：
COVID-19：中国Shinofarm疫苗：秘鲁的“试验中止”
ー参加者の腕が麻痺ー
中国：シノファーム
ペルー国立保健院：
現在 、中国国有製薬・ワクチンの治験が、ペルー国内で進められている。
ペルー国立保健院は、“シノファーム”COVID-19ワクチンの治験を、突然中断した。
12月11日（現地時間）、理由を明らかにした。
フランスのAFP通信：
今回の臨床試験の中断は、参加者1人が“ギラン・バレー症候群”で腕を動かせなくなったことによる措置とのこと。
wowkorea.jp
http://www.wowkorea.jp/news/Korea/2020/1212/10280470.html
Peru suspends clinical trials of Chinese COVID-19 vaccine
LIMA: Peru
has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health
said on Friday (Dec 11) that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
Several days ago
we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms
which could correspond to a condition called Guillain-Barre syndrome,” said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome
is a rare and non-contagious disorder which affects the movement of the arms and legs.
Peru declared
a temporary health emergency in five regions in June last year following multiple cases.
CNA
Peru halts Chinese coronavirus vaccine trials after volunteer develops neurological problems